2023-03-30T16:58:22+08:00 weekly 1.0 https://srla.prisysbiotech.com/ 2024-11-08T17:23:50+08:00 weekly 0.9 https://srla.prisysbiotech.com/metabolic-syndromes-research 2024-11-08T17:23:46+08:00 weekly 0.9 https://srla.prisysbiotech.com/respiratory-disease-research 2024-11-08T17:23:48+08:00 weekly 0.9 https://srla.prisysbiotech.com/hematological-disease-research 2024-11-08T18:43:48+08:00 weekly 0.9 https://srla.prisysbiotech.com/ophthalmic-disease-research 2024-11-08T17:23:58+08:00 weekly 0.9 https://srla.prisysbiotech.com/cns-disorders-behavior-analysis 2023-04-01T15:30:18+08:00 weekly 0.9 https://srla.prisysbiotech.com/co-develop 2024-11-08T17:23:57+08:00 weekly 0.9 https://srla.prisysbiotech.com/inflammation-immunology-disorders 2024-11-08T17:24:31+08:00 weekly 0.9 https://srla.prisysbiotech.com/translational-research-center 2024-11-08T17:27:47+08:00 weekly 0.9 https://srla.prisysbiotech.com/animal-welfare 2024-11-08T17:24:30+08:00 weekly 0.9 https://srla.prisysbiotech.com/download 2024-09-29T14:45:25+08:00 weekly 0.9 https://srla.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://srla.prisysbiotech.com/fibrosis 2024-11-08T17:24:24+08:00 weekly 0.9 https://srla.prisysbiotech.com/about-us 2024-11-08T17:24:23+08:00 weekly 0.9 https://srla.prisysbiotech.com/contact-us 2023-04-01T16:56:57+08:00 weekly 0.9 https://srla.prisysbiotech.com/newslist-1 2024-11-08T18:43:43+08:00 weekly 0.9 https://srla.prisysbiotech.com/products 2023-04-01T13:40:49+08:00 weekly 1.0 https://srla.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T13:40:49+08:00 weekly 0.9 https://srla.prisysbiotech.com/pk-pd-adme/ 2023-04-01T13:40:49+08:00 weekly 0.9 https://srla.prisysbiotech.com/safety-evaluation/ 2023-04-01T13:40:50+08:00 weekly 0.9 https://srla.prisysbiotech.com/translation-research/ 2023-04-01T13:40:52+08:00 weekly 0.9 https://srla.prisysbiotech.com/biosafety-research/ 2024-04-10T00:18:16+08:00 weekly 0.9 https://srla.prisysbiotech.com/clearpoint/ 2023-04-01T15:29:59+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2023-04-01T15:37:10+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-08T17:24:01+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2024-11-08T17:23:57+08:00 weekly 0.8 https://srla.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2023-04-01T16:17:54+08:00 weekly 0.8 https://srla.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-08T17:23:54+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2024-11-08T17:23:59+08:00 weekly 0.8 https://srla.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-08T17:23:59+08:00 weekly 0.8 https://srla.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-04-01T16:51:30+08:00 weekly 0.8 https://srla.prisysbiotech.com/pk-pd-adme/adme.html 2023-04-01T16:51:31+08:00 weekly 0.8 https://srla.prisysbiotech.com/safety-evaluation/toxicology.html 2023-04-01T16:51:33+08:00 weekly 0.8 https://srla.prisysbiotech.com/translation-research/translational-studies.html 2023-04-01T16:51:36+08:00 weekly 0.8 https://srla.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-08T17:24:10+08:00 weekly 0.8 https://srla.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-11-08T17:24:04+08:00 weekly 0.8 https://srla.prisysbiotech.com/translation-research/nhpresources.html 2024-11-08T17:24:11+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-11-08T18:43:50+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-08T17:24:13+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-04-01T16:51:52+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-04-01T16:51:54+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2024-11-08T17:24:18+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-04-01T16:56:23+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2023-04-01T16:56:35+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-04-01T16:56:33+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2023-04-01T16:56:37+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2023-04-01T16:56:39+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-04-01T16:56:44+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-08T17:24:15+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2024-11-08T17:24:11+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-08T17:24:25+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-08T17:24:23+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-04-01T16:56:50+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-08T17:24:23+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-08T17:24:24+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-08T17:24:25+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-08T18:43:41+08:00 weekly 0.8 https://srla.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2023-04-01T18:29:48+08:00 weekly 0.8 https://srla.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-08T22:38:45+08:00 weekly 0.8 https://srla.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-08T17:24:45+08:00 weekly 0.8 https://srla.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-08T17:28:18+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-09T06:33:05+08:00 weekly 0.8 https://srla.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-30T11:10:36+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-30T11:10:55+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-11-08T17:28:17+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-30T11:10:40+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-30T11:10:44+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-30T11:10:47+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-09-30T17:07:11+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-12-10T07:47:41+08:00 weekly 0.8 https://srla.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-10T07:47:43+08:00 weekly 0.8 https://srla.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-03-31T08:07:08+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-03-31T08:07:02+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-07-19T20:36:47+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-19T20:36:57+08:00 weekly 0.8 https://srla.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-09-03T21:24:26+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-16T01:29:22+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T04:57:08+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-25T02:38:00+08:00 weekly 0.8 https://srla.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-09-29T14:42:17+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-23T01:09:06+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T15:04:48+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-04-29T09:16:59+08:00 weekly 0.8 https://srla.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-04-29T09:17:20+08:00 weekly 0.8 https://srla.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2026-04-29T09:17:02+08:00 weekly 0.8 https://srla.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-04-29T09:17:19+08:00 weekly 0.8 https://srla.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html 2026-05-25T16:09:46+08:00 weekly 0.8 https://srla.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html 2026-05-25T16:09:12+08:00 weekly 0.8 https://srla.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html 2023-04-01T13:40:47+08:00 weekly 0.9 https://srla.prisysbiotech.com/newslist-714495-1 2023-04-01T13:40:47+08:00 weekly 0.9 https://srla.prisysbiotech.com/newslist-714496-1 2024-07-30T02:40:45+08:00 weekly 0.9 https://srla.prisysbiotech.com/newslist-818822-1 2026-04-29T09:15:54+08:00 weekly 0.9 https://srla.prisysbiotech.com/newslist-17850974922449920-1 2023-04-01T15:28:21+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/meetprisys-sot2023-66146855.html 2023-04-01T15:28:20+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66146856.html 2023-04-01T15:28:20+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66146857.html 2023-04-01T15:28:24+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66146858.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-sot2023-66146859.html 2023-04-01T15:28:26+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66146860.html 2023-04-01T15:28:27+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/gene-therapy-nhp-model-66146861.html 2023-04-01T15:28:28+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66146862.html 2023-04-01T15:28:32+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66146863.html 2023-04-01T17:07:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66150073.html 2023-04-06T22:35:51+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/gene-therapy-toxicology-66269075.html 2023-05-05T11:51:13+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67241004.html 2023-05-05T11:51:12+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/world-parkinsons-disease-day-67241005.html 2023-05-05T11:51:16+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67241006.html 2023-05-05T11:51:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67241007.html 2023-05-05T11:51:15+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67241008.html 2023-05-05T11:51:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67241009.html 2023-05-05T11:51:06+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67241010.html 2023-05-05T11:51:13+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67241011.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68290915.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68290919.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68290926.html 2023-06-10T15:13:47+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68320749.html 2023-06-18T09:50:20+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68564655.html 2023-07-09T05:02:27+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69067090.html 2023-07-09T05:02:30+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69067094.html 2023-07-09T05:02:29+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69067095.html 2023-07-09T05:02:31+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69067110.html 2023-07-09T05:02:28+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69067119.html 2023-07-09T05:02:25+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69067133.html 2023-07-17T10:26:47+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69310248.html 2023-07-17T10:26:20+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69310249.html 2023-07-17T10:26:22+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69310250.html 2023-07-17T10:26:27+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69310252.html 2023-08-03T09:20:40+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69708848.html 2023-08-03T09:20:38+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69708849.html 2023-09-14T13:30:09+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/0-71000904.html 2023-09-14T13:30:10+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71000905.html 2023-09-14T13:30:10+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71000910.html 2023-09-14T13:30:11+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71000913.html 2023-09-14T13:30:11+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71000914.html 2023-09-14T13:30:15+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71000919.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72324941.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72324945.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72324946.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72324948.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72324952.html 2023-11-21T17:00:10+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72680474.html 2023-12-04T23:26:36+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73013225.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73533113.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73534270.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74221132.html 2024-01-30T08:48:23+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74754745.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74864383.html 2024-11-08T17:17:45+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75182786.html 2024-02-22T15:32:24+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75182787.html 2024-03-29T07:24:18+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76213351.html 2024-04-27T09:03:10+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77065008.html 2024-05-24T21:26:15+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77718303.html 2024-11-08T17:17:48+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77718304.html 2024-11-08T17:27:49+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79194287.html 2024-07-20T03:14:56+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-asthma-model-79194288.html 2024-07-20T03:14:54+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79194289.html 2024-07-20T03:14:56+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79194293.html 2024-11-08T17:27:54+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79194294.html 2024-11-08T17:27:58+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79419058.html 2024-11-08T18:44:15+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79419059.html 2024-11-08T17:28:00+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79419060.html 2024-11-08T17:27:57+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pk-strategies-of-pdc-79545563.html 2024-08-03T04:17:53+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79545564.html 2024-11-08T17:28:01+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79545565.html 2024-08-03T04:17:53+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79545566.html 2024-08-03T04:17:48+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79545567.html 2024-08-03T04:17:49+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79545568.html 2024-08-03T04:17:48+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79545569.html 2024-08-03T04:17:54+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79545570.html 2024-08-03T04:18:08+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79545581.html 2024-08-03T04:18:11+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79545586.html 2024-08-03T04:18:10+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79545587.html 2024-11-08T17:27:56+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79545588.html 2024-08-03T04:18:45+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79545589.html 2024-11-08T17:28:00+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79545590.html 2024-08-03T04:18:40+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79545591.html 2024-08-03T04:18:50+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79545592.html 2024-08-03T04:18:53+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79545593.html 2024-08-03T04:18:58+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/significance-principles-and-requirements-of-79545594.html 2024-08-03T04:19:00+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79545595.html 2024-08-03T04:19:00+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79545596.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79545597.html 2024-08-03T04:19:04+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79545598.html 2024-08-03T04:19:04+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79545599.html 2024-08-03T04:19:12+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79545600.html 2024-08-03T04:19:09+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79545601.html 2024-08-03T04:19:10+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79545602.html 2024-08-03T04:19:10+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79545603.html 2024-11-08T17:28:04+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79545604.html 2024-08-03T04:19:16+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79545605.html 2024-08-03T04:19:20+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79545606.html 2024-08-03T04:19:21+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79545607.html 2024-08-03T04:19:19+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79545608.html 2024-08-03T04:19:20+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79545609.html 2024-11-08T17:28:05+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79545610.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79545611.html 2024-08-03T04:19:25+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79545612.html 2024-11-08T17:28:04+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79545613.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79545614.html 2024-08-03T04:19:35+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79545615.html 2024-08-03T04:19:37+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79545616.html 2024-08-03T04:19:28+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79545617.html 2024-08-03T04:19:38+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79545618.html 2024-08-03T04:19:38+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79545619.html 2024-08-03T04:19:39+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79545620.html 2024-08-03T04:19:40+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/mrna-based-therapies-present-79545621.html 2024-11-08T17:28:07+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/mrna-based-therapies-past-79545623.html 2024-08-03T04:19:42+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79545624.html 2024-08-07T08:44:22+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656464.html 2024-09-30T11:10:19+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81225464.html 2024-09-30T11:10:29+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81225465.html 2024-09-30T11:10:34+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/compartment-pk-model-81225466.html 2024-09-30T11:10:34+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81225467.html 2024-09-30T11:10:26+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/human-disease-animal-models-81225468.html 2024-09-30T11:10:32+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/animal-models-of-human-diseases-81225469.html 2024-11-08T18:44:21+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81225470.html 2024-11-08T17:28:11+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/convection-enhanced-delivery-81225471.html 2024-09-30T11:10:32+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81225472.html 2024-09-30T11:10:33+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81225473.html 2024-09-30T11:10:27+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81225474.html 2024-09-30T11:10:28+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/china-experimental-monkey-industry-81225475.html 2024-09-30T11:10:44+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81225476.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82254917.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82781493.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82781494.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82781495.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82781496.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82781497.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82781498.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82781501.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82781504.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82781506.html 2024-12-10T07:47:47+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83093395.html 2024-12-10T07:47:45+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83093399.html 2024-12-10T07:47:52+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83093402.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84106992.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84106995.html 2025-01-25T10:15:01+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84106996.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84106997.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84106999.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84107000.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84107002.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84107004.html 2025-01-16T06:24:45+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84129328.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17253035927168000.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17253036172616704.html 2025-03-31T08:07:08+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17293153462543360.html 2025-03-31T08:07:08+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17293153634280448.html 2025-03-31T08:07:19+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17293153635066880.html 2025-03-31T08:07:16+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17293153712432128.html 2025-03-31T08:07:21+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17293153803019264.html 2025-03-31T08:07:37+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17293153835869184.html 2025-03-31T08:07:21+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17293153913136128.html 2025-03-31T08:07:20+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/animal-models-for-womens-health-17293153944658944.html 2025-03-31T08:07:22+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17293154047419392.html 2025-03-31T08:07:25+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/membranous-nephropathy-model-17293154133763072.html 2025-03-31T08:07:39+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17293154191696896.html 2025-03-31T08:07:39+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17293154197398528.html 2025-03-31T08:07:38+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17293154286101504.html 2025-03-31T08:07:37+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17293154462835712.html 2025-03-31T08:29:16+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17293174855181312.html 2025-03-31T08:29:31+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17293175157695488.html 2025-03-31T08:48:09+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17293196886631424.html 2025-04-06T01:28:58+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17301220147880960.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17381103339807744.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17381103905547264.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17381105007256576.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17381107068773376.html 2025-06-01T10:58:48+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17381108287644672.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/intracerebroventricular-icv-injection-17381109725242368.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17381110815532032.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17381111712064512.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17381112411546624.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17381114217899008.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17381115303994368.html 2025-06-01T11:32:53+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17381126324593664.html 2025-07-19T20:36:44+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17449606474179584.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17449606689432576.html 2025-07-19T20:37:49+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17449606891856896.html 2025-07-19T20:37:22+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17449607155590144.html 2025-07-19T20:38:00+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/key-considerations-for-dosing-volume-17449607196533760.html 2025-07-19T20:37:08+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17449607312024576.html 2025-07-19T20:37:43+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17449607465509888.html 2025-07-19T20:37:34+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17449607530849280.html 2025-07-19T20:37:19+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17449607646536704.html 2025-07-19T20:38:29+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17449608243618816.html 2025-07-19T20:38:28+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17449608255742976.html 2025-07-19T20:54:16+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17449626081436672.html 2025-09-03T20:30:08+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-copd-model-17514686789411840.html 2025-09-03T20:30:05+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17514686797931520.html 2025-09-03T20:30:45+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17514686844183552.html 2025-09-03T20:29:51+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17514686845051904.html 2025-09-03T20:30:39+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17514686929757184.html 2025-09-03T20:30:22+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17514686946157568.html 2025-09-16T01:29:20+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/the-importance-of-administration-volume-17532009853068288.html 2025-09-16T01:29:34+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17532009909789696.html 2025-09-16T01:29:23+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17532009940640768.html 2025-09-16T01:29:31+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17532009954223104.html 2025-09-16T01:29:22+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/brain-targeted-drug-delivery-17532009985205248.html 2025-09-16T01:29:27+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17532010027197440.html 2025-09-16T01:29:28+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17532010028229632.html 2025-09-20T04:57:05+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17537851607688192.html 2025-09-29T16:37:10+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17551274315932672.html 2025-12-11T00:12:33+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17653674946126848.html 2025-12-11T00:12:23+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17653674997638144.html 2025-12-11T00:12:38+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17653675020035072.html 2025-12-11T00:13:08+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-renal-biopsy-17653675410318336.html 2025-12-11T00:12:34+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17653675512079360.html 2025-12-11T00:12:58+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17653675551417344.html 2025-12-11T00:13:08+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17653675690320896.html 2025-12-11T00:13:09+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17653675899446272.html 2025-12-11T00:13:22+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/rfp-template-for-nhp-studies-17653676037088256.html 2025-12-11T00:13:31+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17653676090205184.html 2025-12-11T00:13:38+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17653676221719552.html 2025-12-23T01:12:13+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17670722924045312.html 2025-12-23T01:12:21+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17670722979062784.html 2025-12-23T01:12:17+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17670722986730496.html 2025-12-23T01:12:28+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17670723024512000.html 2025-12-23T01:12:37+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17670723195364352.html 2025-12-23T01:12:34+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17670723299206144.html 2025-12-23T01:12:42+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17670723312821248.html 2025-12-23T01:12:35+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17670723314541568.html 2025-12-23T01:12:40+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17670723415991296.html 2026-01-29T15:04:44+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17723920401130496.html 2026-01-29T15:04:48+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17723920421168128.html 2026-01-29T15:04:48+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17723920465847296.html 2026-01-29T15:04:49+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17723920504382464.html 2026-01-29T15:04:49+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17723920558269440.html 2026-01-29T15:04:52+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17723920561366016.html 2026-01-29T15:04:52+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17723920570098688.html 2026-01-29T15:04:48+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17723920575636480.html 2026-01-29T15:04:54+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17723920670761984.html 2026-01-29T15:04:56+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17723920687539200.html 2026-04-29T09:16:09+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17850975027422208.html 2026-04-29T09:16:08+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17850975096710144.html 2026-04-29T09:16:21+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17850975225013248.html 2026-04-29T09:16:28+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/evaluating-dmpk-properties-17850975282783232.html 2026-04-29T09:16:21+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17850975305212928.html 2026-04-29T09:16:07+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17850975310193664.html 2026-04-29T09:16:21+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17850975326594048.html 2026-04-29T09:16:29+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17850975358723072.html 2026-04-29T09:16:29+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17850975423996928.html 2026-04-29T09:16:38+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17850975465415680.html 2026-04-29T09:16:36+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17850975490057216.html 2026-06-20T11:08:14+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17850975530771456.html 2026-04-29T09:16:46+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17850975608824832.html 2026-04-29T09:17:00+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17850975886205952.html 2026-04-29T09:17:26+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17850976047539200.html 2026-04-29T09:21:48+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17850980483916800.html 2026-05-25T16:09:15+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888188978979840.html 2026-05-25T16:09:09+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888189241484288.html 2026-05-25T16:09:12+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/nhp-models-translational-drug-development-17888189528335360.html 2026-05-25T16:09:23+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888189877756928.html 2026-05-25T16:12:43+08:00 weekly 0.8 https://srla.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888191495791616.html